Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection

被引：7
作者：
Smith, Michael A. [1 ]
Mohammad, Rima A. [2 ]
机构：
[1] Univ Sci Philadelphia, Philadelphia Coll Pharm, Philadelphia, PA USA
[2] Univ Michigan, Coll Pharm, UMHS Pharm Serv, Ann Arbor, MI 48109 USA
来源：
LANCET INFECTIOUS DISEASES | 2015年 / 15卷 / 09期
关键词：
HCV;
D O I：
10.1016/S1473-3099(15)00223-6
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：993 / 995
页数：4
相关论文
共 11 条
  • [1] AASLD and IDSA, REC TEST MAN TREAT H
  • [2] Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
    Afdhal, Nezam
    Zeuzem, Stefan
    Kwo, Paul
    Chojkier, Mario
    Gitlin, Norman
    Puoti, Massimo
    Romero-Gomez, Manuel
    Zarski, Jean-Pierre
    Agarwal, Kosh
    Buggisch, Peter
    Foster, Graham R.
    Braeu, Norbert
    Buti, Maria
    Jacobson, Ira M.
    Subramanian, G. Mani
    Ding, Xiao
    Mo, Hongmei
    Yang, Jenny C.
    Pang, Phillip S.
    Symonds, William T.
    McHutchison, John G.
    Muir, Andrew J.
    Mangia, Alessandra
    Marcellin, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20) : 1889 - 1898
  • [3] Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
    Afdhal, Nezam
    Reddy, K. Rajender
    Nelson, David R.
    Lawitz, Eric
    Gordon, Stuart C.
    Schiff, Eugene
    Nahass, Ronald
    Ghalib, Reem
    Gitlin, Norman
    Herring, Robert
    Lalezari, Jacob
    Younes, Ziad H.
    Pockros, Paul J.
    Di Bisceglie, Adrian M.
    Arora, Sanjeev
    Subramanian, G. Mani
    Zhu, Yanni
    Dvory-Sobol, Hadas
    Yang, Jenny C.
    Pang, Phillip S.
    Symonds, William T.
    McHutchison, John G.
    Muir, Andrew J.
    Sulkowski, Mark
    Kwo, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16) : 1483 - 1493
  • [4] IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4
    Antaki, N.
    Bibert, S.
    Kebbewar, K.
    Asaad, F.
    Baroudi, O.
    Alideeb, S.
    Hadad, M.
    Abboud, D.
    Sabah, H.
    Bochud, P. -Y.
    Negro, F.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 (01) : 59 - 64
  • [5] Esmat GE, 2014, 65 ANN M AM ASS STUD
  • [6] Kohli A, 2015, LANCET INFECT DIS
  • [7] Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
    Kowdley, Kris V.
    Gordon, Stuart C.
    Reddy, K. Rajender
    Rossaro, Lorenzo
    Bernstein, David E.
    Lawitz, Eric
    Shiffman, Mitchell L.
    Schiff, Eugene
    Ghalib, Reem
    Ryan, Michael
    Rustgi, Vinod
    Chojkier, Mario
    Herring, Robert
    Di Bisceglie, Adrian M.
    Pockros, Paul J.
    Subramanian, G. Mani
    An, Di
    Svarovskaia, Evguenia
    Hyland, Robert H.
    Pang, Phillip S.
    Symonds, William T.
    McHutchison, John G.
    Muir, Andrew J.
    Pound, David
    Fried, Michael W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20) : 1879 - 1888
  • [8] Molina JM, 2014, 20 INT AIDS C 2014
  • [9] Pol S, 2014, 65 ANN M AM ASS STUD
  • [10] Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients
    Rossi, E
    Adams, L
    Prins, A
    Bulsara, M
    de Boer, B
    Garas, G
    MacQuillan, G
    Speers, D
    Jeffrey, G
    [J]. CLINICAL CHEMISTRY, 2003, 49 (03) : 450 - 454
12